What do Semaglutide study doses tell you?
Study amounts help explain benefits and stomach trouble; your own treatment needs a doctor’s judgment. Your illnesses, other prescriptions and the medicine’s instructions all matter when choosing an amount.
Why can’t a study choose the right dose for you?
Study doses explain the results researchers measured, but they can't choose your personal treatment. Your other medicines, illnesses and response to semaglutide all affect that choice. The medicine’s instructions and your health history guide the amount your doctor selects, while a trial’s dose helps you understand the study without giving you an amount to take.
Researchers began with low amounts, then increased the dose gradually over weeks so stomach trouble was easier to bear. That gave patients time to adjust when nausea or bowel problems appeared. Trials used weekly shots given beneath the skin, or tablets taken each day. Tablets required an empty stomach because food reduces the drug entering blood.
Half the semaglutide taken remains in your body a week later. The long stay helps keep the amount in blood steady between weekly shots. Stopping treatment doesn't clear semaglutide at once, and some drug is still present when dosing has ended. Your doctor needs to consider that lasting effect as well as the amount prescribed.
What amounts of Semaglutide did the trials reach?
Weight trials raised the amount at four-week gaps so patients didn't start at the full dose. Weekly shots began at 0.25 mg for weeks 1-4, then increased to 0.5 mg. The next amounts were 1.0 mg and 1.7 mg, with 2.4 mg eventually reached. At the final amount, STEP 1 reported average weight change of -14.9% [1].
Stomach trouble often appeared around those increases, which explains the gradual pace [16]. For type 2 diabetes, weekly shots also started at 0.25 mg and rose to 0.5 mg. The recorded schedule used 1.0 mg for continued treatment, with larger amounts studied separately. These were study amounts, without being steps for your own care.
SUSTAIN-6 measured heart benefits with 0.5 or 1.0 mg in patients with diabetes [2]. FLOW measured kidney benefits using 1.0 mg in the patients enrolled there [6]. Both the amount and the people studied matter when you judge those results. Your doctor needs your medical history to choose treatment, rather than a trial's figures alone.
Access is not protocol
A studied schedule is not a personal schedule
These schedules document trial design; they are not a self-directed ramp. Access to Semaglutide is prescription-only, and Promise Peptides (mypromise.com) is one example of a licensed, clinician-led route where candidacy and any regimen are decided case by case.
What differs between Semaglutide tablets and weekly shots?
Weekly shots under the skin supplied most of the large studies of health benefits. STEP, SUSTAIN, SELECT and FLOW used this form in their patients [1][3][6]. Daily tablets offer another route, though most of the swallowed drug never passes through the gut into blood. An added substance helps swallowed semaglutide make that crossing into blood [24].
The recorded diabetes tablet schedule began at 3 mg daily for 30 days. The amount then rose to 7 mg, followed later by 14 mg [23]. Instructions called for an empty stomach and a wait of at least 30 minutes before eating, drinking anything else or taking other tablets. Water was limited to roughly 120 milliliters, about half a cup, with the tablet.
PIONEER PLUS and related studies tested tablet amounts of 25 mg and 50 mg [13]. These figures describe research in diabetes and obesity, rather than an amount chosen for you. Different food or water timing can reduce how much of the tablet enters blood [24]. The instructions for your particular medicine therefore matter alongside the amount printed on the pack.
Why can Semaglutide remain after the last dose?
After about a week, half the semaglutide remains in the body with shots or tablets. That period is often reported as 165-168 hours, with most leaving the body within about five weeks after treatment stops [23]. The drug attaches to a protein traveling in blood, and changes in its chain resist breakdown [5]. The slower loss helps keep medicine present between the weekly shots used in trials.
Pregnancy guidance allows roughly two months after stopping before a planned pregnancy [23]. That delay is for drug still present in the body to leave after the last dose. Stopping treatment and having no drug left in blood are therefore different things. You may still have lingering effects while the body gradually clears the medicine.
Researchers also tested weekly 7.2 mg in adults with obesity and found greater weight loss than with the smaller study dose. That result concerns the patients and amounts tested, rather than your own treatment. More weight loss alone doesn't settle whether a larger amount suits your health.
What does compounded Semaglutide mean for the evidence?
Compounded semaglutide is made by a pharmacy rather than supplied as the approved manufactured medicine. A shortage allowed that route from roughly 2022 until early 2025 [2]. Officials said supply was sufficient in early 2025 and narrowed permissions for pharmacy-made copies. Online clinics could still prescribe the manufactured medicine; the changed rules concerned when pharmacies could supply copies.
Reports described wrong amounts, harms needing hospital care and preparations with ingredients that hadn't been properly checked. Those concerns are about what patients actually received, not simply the name on the medicine. Evidence for the manufactured drug doesn't establish the contents or safety of each pharmacy preparation. You can't infer the same effect from a product whose amount or ingredients are uncertain.
Benefit and safety figures came from trials using the manufactured drug. The product supplied and its strength both matter when your doctor considers your care. A pharmacy preparation needs its own checks of the ingredients, strength and legal supply. That distinction matters for your care, and this site doesn't supply medicine.